ALT logo

Altimmune (ALT) Cash From Financing

Annual CFF

$86.11 M
+$29.32 M+51.64%

December 31, 2023

Summary

Performance

1-Year Change

+51.64%

3-Year Change

-59.67%

5-Year Change

+165.02%

15-Year Change

+443.54%

ALT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.53%
ALT annual cash flow from financing activities is higher than 84.53% of companies in Healthcare sector

High & Low

All-time High

$213.49 M
ALT annual cash flow from financing activities is currently -59.67% below its historical high of $213.49 million

3-Year Low

$56.78 M
ALT annual cash flow from financing activities is currently +51.64% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ALT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
ALT next annual earnings announcement is scheduled for Mar 27, 2025

OtherALTcash flowmetrics:

Annual CFI

$13.73 M
ALT annual cash flow from investing activities is $13.73 million

Annual CFO

-$75.81 M
ALT annual cash flow from operations is -$75.81 million

Annual FCF

-$75.86 M
ALT annual free cash flow is -$75.86 million

Annual CAPEX

$47.00 K
ALT annual capital expenditures is $47.00 thousand

Quarterly CFF

$266.00 K
+$312.00 K+678.26%

September 30, 2024

Summary

Performance

3-Month Change

+678.26%

1-Year Change

-99.63%

3-Year Change

+112.8%

5-Year Change

+576.7%

ALT Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.66%
ALT quarterly cash flow from financing activities is higher than 54.66% of companies in Healthcare sector

High & Low

All-time High

$136.15 M
ALT quarterly cash flow from financing activities is currently -99.80% below its historical high of $136.15 million

3-Year Low

-$302.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
ALT next earnings announcement is scheduled for Mar 27, 2025

OtherALTcash flowmetrics:

Quarterly CFI

$1.20 M
ALT quarterly cash flow from investing activities is $1.20 million

Quarterly CFO

-$27.12 M
ALT quarterly cash flow from operations is -$27.12 million

Quarterly FCF

-$27.12 M
ALT quarterly free cash flow is -$27.12 million

Quarterly CAPEX

-
ALT quarterly capital expenditures value is unknown

TTM CFF

$72.71 M
-$322.00 K-0.44%

September 30, 2024

Summary

Performance

3-Month Change

-0.44%

1-Year Change

-15.55%

3-Year Change

-3.39%

5-Year Change

+480.21%

ALT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.41%
ALT TTM cash flow from financing activities is higher than 78.41% of companies in Healthcare sector

High & Low

All-time High

$247.81 M
ALT TTM cash flow from financing activities is currently -70.66% below its historical high of $247.81 million

3-Year Low

$13.31 M
ALT TTM cash flow from financing activities is currently +446.39% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ALT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
ALT next earnings announcement is scheduled for Mar 27, 2025

OtherALTcash flowmetrics:

TTM CFI

-$49.98 M
ALT TTM cash flow from investing activities is -$49.98 million

TTM CFO

-$78.12 M
ALT TTM cash flow from operations is -$78.12 million

TTM FCF

-$78.12 M
ALT TTM free cash flow is -$78.12 million

TTM CAPEX

-
ALT TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ALT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+51.6%-99.6%-15.6%
3 y3 years-59.7%+112.8%-3.4%
5 y5 years+165.0%+576.7%+480.2%

ALT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+51.6%-99.6%+188.1%-15.6%+446.4%
5 y5-year-59.7%+587.1%-99.8%+188.1%-70.7%>+9999.0%
alltimeall time-59.7%>+9999.0%-99.8%+107.7%-70.7%+2367.9%

Altimmune Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$266.00 K(-678.3%)
$72.71 M(-0.4%)
Jun 2024
-
-$46.00 K(-82.4%)
$73.03 M(-15.2%)
Mar 2024
-
-$261.00 K(-100.4%)
$86.15 M(+0.0%)
Dec 2023
$86.11 M(+51.6%)
$72.75 M(>+9900.0%)
$86.11 M(+547.0%)
Sep 2023
-
$588.00 K(-95.5%)
$13.31 M(-70.3%)
Jun 2023
-
$13.06 M(-4426.2%)
$44.78 M(-16.0%)
Mar 2023
-
-$302.00 K(+602.3%)
$53.30 M(-6.1%)
Dec 2022
$56.78 M(-12.8%)
-$43.00 K(-100.1%)
$56.78 M(-18.1%)
Sep 2022
-
$32.06 M(+48.5%)
$69.36 M(+85.3%)
Jun 2022
-
$21.58 M(+578.5%)
$37.42 M(+10.5%)
Mar 2022
-
$3.18 M(-74.6%)
$33.86 M(-48.0%)
Dec 2021
$65.10 M(-69.5%)
$12.54 M(>+9900.0%)
$65.10 M(-13.5%)
Sep 2021
-
$125.00 K(-99.3%)
$75.27 M(-64.4%)
Jun 2021
-
$18.02 M(-47.6%)
$211.29 M(-14.7%)
Mar 2021
-
$34.42 M(+51.6%)
$247.81 M(+16.1%)
Dec 2020
$213.49 M(+1603.5%)
$22.70 M(-83.3%)
$213.49 M(+11.9%)
Sep 2020
-
$136.15 M(+149.6%)
$190.83 M(+249.3%)
Jun 2020
-
$54.54 M(>+9900.0%)
$54.63 M(<-9900.0%)
Mar 2020
-
$96.70 K(+115.4%)
-$70.30 K(-100.6%)
Dec 2019
$12.53 M(-61.4%)
$44.90 K(-180.5%)
$12.53 M(-71.5%)
Sep 2019
-
-$55.80 K(-64.3%)
$44.01 M(-9.2%)
Jun 2019
-
-$156.10 K(-101.2%)
$48.47 M(+7.3%)
Mar 2019
-
$12.70 M(-59.7%)
$45.17 M(+39.0%)
Dec 2018
$32.49 M(+105.1%)
$31.52 M(+614.3%)
$32.49 M(+3244.3%)
Sep 2018
-
$4.41 M(-227.5%)
$971.50 K(-89.8%)
Jun 2018
-
-$3.46 M(<-9900.0%)
$9.55 M(-25.4%)
Mar 2018
-
$18.50 K(>+9900.0%)
$12.81 M(-19.2%)
Dec 2017
$15.84 M(+217.9%)
$0.00(-100.0%)
$15.84 M(+4.6%)
Sep 2017
-
$12.99 M(-6568.1%)
$15.15 M(+258.9%)
Jun 2017
-
-$200.80 K(-106.6%)
$4.22 M(-47.3%)
Mar 2017
-
$3.05 M(-541.4%)
$8.01 M(+60.8%)
Dec 2016
$4.98 M(+2133.3%)
-$691.90 K(-133.6%)
$4.98 M(-12.6%)
Sep 2016
-
$2.06 M(-42.7%)
$5.70 M(+44.0%)
Jun 2016
-
$3.59 M(>+9900.0%)
$3.96 M(+863.6%)
Mar 2016
-
$22.40 K(-24.1%)
$411.10 K(+84.3%)
Dec 2015
$223.10 K
$29.50 K(-90.7%)
$223.00 K(-91.9%)
Sep 2015
-
$317.00 K(+651.2%)
$2.74 M(-78.8%)
DateAnnualQuarterlyTTM
Jun 2015
-
$42.20 K(-125.5%)
$12.93 M(-14.9%)
Mar 2015
-
-$165.70 K(-106.5%)
$15.19 M(-9.2%)
Dec 2014
$16.73 M(+232.7%)
$2.55 M(-75.7%)
$16.73 M(+11.7%)
Sep 2014
-
$10.50 M(+355.2%)
$14.97 M(+181.7%)
Jun 2014
-
$2.31 M(+67.4%)
$5.32 M(-17.8%)
Mar 2014
-
$1.38 M(+74.0%)
$6.47 M(+28.6%)
Dec 2013
$5.03 M(+35.2%)
$791.70 K(-5.8%)
$5.03 M(+15.4%)
Sep 2013
-
$840.30 K(-75.7%)
$4.36 M(-7.8%)
Jun 2013
-
$3.46 M(-5825.8%)
$4.73 M(+939.2%)
Mar 2013
-
-$60.40 K(-149.5%)
$455.00 K(-87.8%)
Dec 2012
$3.72 M(-35.7%)
$122.10 K(-89.9%)
$3.72 M(+2.5%)
Sep 2012
-
$1.21 M(-248.3%)
$3.63 M(+52.9%)
Jun 2012
-
-$815.10 K(-125.4%)
$2.37 M(-73.6%)
Mar 2012
-
$3.20 M(>+9900.0%)
$8.97 M(+55.2%)
Dec 2011
$5.78 M(-73.1%)
$31.10 K(-164.9%)
$5.78 M(-73.3%)
Sep 2011
-
-$47.90 K(-100.8%)
$21.63 M(-14.0%)
Jun 2011
-
$5.79 M(>+9900.0%)
$25.15 M(+16.4%)
Mar 2011
-
$12.80 K(-99.9%)
$21.60 M(+0.6%)
Dec 2010
$21.46 M(+14.2%)
$15.88 M(+357.3%)
$21.46 M(+274.1%)
Sep 2010
-
$3.47 M(+55.4%)
$5.74 M(-7.9%)
Jun 2010
-
$2.24 M(-1885.2%)
$6.23 M(-40.3%)
Mar 2010
-
-$125.20 K(-181.5%)
$10.44 M(-44.5%)
Dec 2009
$18.79 M(+679.5%)
$153.70 K(-96.1%)
$18.79 M(-22.5%)
Sep 2009
-
$3.96 M(-38.5%)
$24.25 M(+27.1%)
Jun 2009
-
$6.45 M(-21.7%)
$19.08 M(+64.0%)
Mar 2009
-
$8.23 M(+46.5%)
$11.64 M(+382.9%)
Dec 2008
$2.41 M(-96.1%)
$5.62 M(-565.6%)
$2.41 M(-175.2%)
Sep 2008
-
-$1.21 M(+20.6%)
-$3.21 M(+60.3%)
Jun 2008
-
-$1.00 M(0.0%)
-$2.00 M(+100.0%)
Mar 2008
-
-$1.00 M(-111.1%)
-$1.00 M(-104.9%)
Dec 2007
$61.93 M(+442.0%)
-
-
Mar 2007
-
$9.02 M(+1071.4%)
$20.44 M(+78.9%)
Dec 2006
$11.43 M(-83.6%)
$769.60 K(-92.8%)
$11.43 M(+7.2%)
Sep 2006
-
$10.66 M(>+9900.0%)
$10.66 M(>+9900.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00
$0.00
Dec 2005
$69.48 M
-
-

FAQ

  • What is Altimmune annual cash flow from financing activities?
  • What is the all time high annual CFF for Altimmune?
  • What is Altimmune annual CFF year-on-year change?
  • What is Altimmune quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Altimmune?
  • What is Altimmune quarterly CFF year-on-year change?
  • What is Altimmune TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Altimmune?
  • What is Altimmune TTM CFF year-on-year change?

What is Altimmune annual cash flow from financing activities?

The current annual CFF of ALT is $86.11 M

What is the all time high annual CFF for Altimmune?

Altimmune all-time high annual cash flow from financing activities is $213.49 M

What is Altimmune annual CFF year-on-year change?

Over the past year, ALT annual cash flow from financing activities has changed by +$29.32 M (+51.64%)

What is Altimmune quarterly cash flow from financing activities?

The current quarterly CFF of ALT is $266.00 K

What is the all time high quarterly CFF for Altimmune?

Altimmune all-time high quarterly cash flow from financing activities is $136.15 M

What is Altimmune quarterly CFF year-on-year change?

Over the past year, ALT quarterly cash flow from financing activities has changed by -$72.49 M (-99.63%)

What is Altimmune TTM cash flow from financing activities?

The current TTM CFF of ALT is $72.71 M

What is the all time high TTM CFF for Altimmune?

Altimmune all-time high TTM cash flow from financing activities is $247.81 M

What is Altimmune TTM CFF year-on-year change?

Over the past year, ALT TTM cash flow from financing activities has changed by -$13.39 M (-15.55%)